Abstract
Background:There is an urgent need to increase diversity among scientific investigators in the HIV research field to be more reflective of communities highly affected by the HIV epidemic. Thus, it is critical to promote the inclusion and advancement of early-stage scholars from racial and ethnic groups underrepresented in HIV science and medicine.Methods:To widen the HIV research career pathway for early-stage scholars from underrepresented minority groups, the National Institutes of Health supported the development of the Centers for AIDS Research (CFAR) Diversity, Equity, and Inclusion Pathway Initiative (CDEIPI). This program was created through partnerships between CFARs and Historically Black Colleges and Universities and other Minority Serving Institutions throughout the United States.Results:Seventeen CFARs and more than 20 Historically Black Colleges and Universities and Minority Serving Institutions have participated in this initiative to date. Programs were designed for the high school (8), undergraduate (13), post baccalaureate (2), graduate (12), and postdoctoral (4) levels. Various pedagogical approaches were used including didactic seminar series, intensive multiday workshops, summer residential programs, and mentored research internship opportunities. During the first 18 months of the initiative, 257 student scholars participated in CDEIPI programs including 150 high school, 73 undergraduate, 3 post baccalaureate, 27 graduate, and 4 postdoctoral students.Conclusion:Numerous student scholars from a wide range of educational levels, geographic backgrounds, and racial and ethnic minority groups have engaged in CDEIPI programs. Timely and comprehensive program evaluation data will be critical to support a long-term commitment to this unique training initiative.
Original language | English (US) |
---|---|
Pages (from-to) | S5-S12 |
Journal | Journal of Acquired Immune Deficiency Syndromes |
Volume | 94 |
Issue number | 2 |
DOIs | |
State | Published - Oct 1 2023 |
Funding
The authors are grateful for the invaluable contributions of the numerous faculty and staff who contributed to the CDEIPI program at collaborating CFARs, HBCUs, and other MSIs. The authors also thank the many CFAR scholars who participated in the inaugural years of the CDEIPI program. The authors respectfully recognize the contributions to the CDEIPI program of Enrique A. Mesri, PhD from the U Miami CFAR who passed away in 2022. In 2021–2022, this initiative was generously supported by the NIH through a supplemental award to the District of Columbia Center for AIDS Research (P30AI117970), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, NIDDK, NIMHD, NIDCR, NINR, FIC and OAR. In 2022–2023, this initiative was supported by the NIH through supplemental awards directly to participating CFARs. The content is solely the responsibility of the authors and does not necessarily represent the official views of their institutions. This article was written by some authors in their capacity as NIH employees, but the views expressed in this article do not necessarily represent those of the NIH. National Institutes of Health (NIH); Supported by the National Institutes of Health through a supplemental award to the District of Columbia Center for AIDS Research (P30AI117970)
Keywords
- CFAR
- diversity
- equity
- inclusion
- pathway
ASJC Scopus subject areas
- Infectious Diseases
- Pharmacology (medical)